antitrust and competition
Services

Antitrust & Competition

When everything is at stake, rely on CRA.

CRA is a global leader in the economic analysis of mergers and non-merger antitrust and competition matters. Empirical and theoretical approaches pioneered by CRA economists have been accepted as standard practice by competition economists and enforcers worldwide.

We tailor our analyses to fit the facts and economics of each case, bringing a unique combination of creativity and rigor to our work. On many occasions, CRA economists have testified in litigated competition cases, or met with and provided submissions to antitrust enforcement agencies. In their testimony, submissions, and meetings with government enforcers—and in discussions with clients—our experts distill complex competition issues and economic analyses into concepts and arguments that are understandable to non-economists.

Our expertise in antitrust economics, econometrics, mergers, acquisitions, divestitures, and related matters has made us the firm of choice for clients and competition authorities around the globe. Our US, Canada, UK, European Union, and Brazil-based antitrust economists have the economic knowledge, jurisdiction-specific expertise, and geographic presence required to efficiently support clients around the world.

Competition expertise around the world

Engagements

  • 01
    Expert report on supply chain, control rights, and social harm
    Senior Consultant to CRA’s Antitrust & Competition Practice, Thomas Hubbard was retained by Wallace and Graham on behalf of the Plaintiffs – hundreds of...
    View engagement
  • 02
    Evaluation of alleged manipulation of industry drug standard setting
    In a matter involving alleged abuse of the U.S. Pharmacopeia standard setting process, CRA examined market power for product dispensed through hospital and...
    View engagement
  • 03
    Alleged foreclosure from API supply agreements
    CRA was retained by a plaintiff generic manufacturer in antitrust litigation involving an infused hospital pharmaceutical product. At issue were claims...
    View engagement

Contact an Antitrust & Competition expert.

See all Antitrust & Competition experts

Subscribe to receive our latest Insights.

Subscribe